Literature DB >> 25274303

Lung disease: Treatment by cell transplant.

Mary Jane Thomassen1, Mani S Kavuru2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25274303     DOI： 10.1038/nature13758

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  20 in total

1.  Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice.

Authors:  Anagha Malur; Anna D Baker; Almedia J McCoy; Greg Wells; Barbara P Barna; Mani S Kavuru; Achut G Malur; Mary Jane Thomassen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

2.  Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.

Authors:  M J Thomassen; T Yi; B Raychaudhuri; A Malur; M S Kavuru
Journal:  Clin Immunol       Date:  2000-05       Impact factor: 3.969

3.  Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis.

Authors:  Christine Happle; Nico Lachmann; Jelena Škuljec; Martin Wetzke; Mania Ackermann; Sebastian Brennig; Adele Mucci; Adan Chari Jirmo; Stephanie Groos; Anja Mirenska; Christina Hennig; Thomas Rodt; Jens P Bankstahl; Nicolaus Schwerk; Thomas Moritz; Gesine Hansen
Journal:  Sci Transl Med       Date:  2014-08-20       Impact factor: 17.956

4.  An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.

Authors:  M S Kavuru; A Malur; I Marshall; B P Barna; M Meziane; I Huizar; H Dalrymple; R Karnekar; M J Thomassen
Journal:  Eur Respir J       Date:  2011-04-08       Impact factor: 16.671

5.  Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units.

Authors:  Carol Jean Saunders; Neil Andrew Miller; Sarah Elizabeth Soden; Darrell Lee Dinwiddie; Aaron Noll; Noor Abu Alnadi; Nevene Andraws; Melanie LeAnn Patterson; Lisa Ann Krivohlavek; Joel Fellis; Sean Humphray; Peter Saffrey; Zoya Kingsbury; Jacqueline Claire Weir; Jason Betley; Russell James Grocock; Elliott Harrison Margulies; Emily Gwendolyn Farrow; Michael Artman; Nicole Pauline Safina; Joshua Erin Petrikin; Kevin Peter Hall; Stephen Francis Kingsmore
Journal:  Sci Transl Med       Date:  2012-10-03       Impact factor: 17.956

6.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

8.  ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.

Authors:  Mary Jane Thomassen; Barbara P Barna; Achut G Malur; Tracey L Bonfield; Carol F Farver; Anagha Malur; Heidi Dalrymple; Mani S Kavuru; Maria Febbraio
Journal:  J Lipid Res       Date:  2007-09-11       Impact factor: 5.922

9.  Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.

Authors:  Anagha Malur; Mani S Kavuru; Irene Marshall; Barbara P Barna; Isham Huizar; Reema Karnekar; Mary Jane Thomassen
Journal:  Respir Res       Date:  2012-06-14

10.  Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

Authors:  T Kitamura; N Tanaka; J Watanabe; S Kanegasaki; Y Yamada; K Nakata
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.